A multi-centre, open, investigator initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0.015% on the face and scalp, and 0.05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT)
British Journal of Dermatology Jan 31, 2018
Kim YC, et al. - The aim of this trial was to estimate the effectiveness and safety of ingenol mebutate gel in the treatment of actinic keratosis
(AK) of face/scalp and trunk/extremities in a large Asian (Korean) population. Ingenol mebutate was found to be efficacious in treating AK in Asians, displaying tolerable safety profiles.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
